Dear Sir/Ma''am, Please find intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 w.r.t. Change in Composition of Committees of the Board and Change in the Name of Company Secretary ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd informed BSE that its Board, at a meeting on 27 January 2026, reconstituted three key committees — Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee — by appointing Mr. Anupam Kumar Mishra (Independent Director) as a member in place of Mr. Janak Raj Sharma across all three committees, effective the same day. Post-reconstitution, all three committees are chaired or dominated by Independent Directors (Mrs. Surjeet Kaur and Mr. Parminder Sharma continue). Separately, the Company Secretary & Compliance Officer Pankaj Mahadeo Singh has undergone a name change to Pankaj Singh, with no change in designation, role, or responsibilities. The filing was signed by Managing Director Bhawani Shankar Goyal.
These are routine governance housekeeping changes — one independent director was swapped across three committees and the CS's name was updated (likely a personal/marital name change). No material impact expected on the stock price or shareholder value, though investors may note the committee composition refresh.